Skip to main content

Table 2 Darunavir resistance mutations (n = 120)

From: Effectiveness and risk factors for virological outcome of darunavir-based therapy for treatment-experienced HIV-infected patients

Mutation

n (%)

L33F

42 (35 %)

I84V

40 (33 %)

L10F

22 (18 %)

I47V

12 (10 %)

V32I

9 (7 %)

V11I

7 (5 %)

I50V

5 (4 %)

T74P

5 (4 %)

L76V

5 (4 %)

L89V

5 (4 %)

I54M

3 (2 %)

I54L

2 (1 %)